Trevi Therapeutics TRVI
Last Price
52 Week Range
$3.47 - $14.39
Next Earnings Date
Mar 17 2026 (Estimate)
Next Earnings Date
Mar 17 2026 (Est.)
Last Price
TRVI Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Trevi Therapeutics, Inc. | 8-K | December 5, 2025 | |
Trevi Therapeutics, Inc. | 8-K | November 13, 2025 | |
Trevi Therapeutics, Inc. | 10-Q | November 13, 2025 | |
Trevi Therapeutics, Inc. | S3ASR | November 13, 2025 | |
Trevi Therapeutics, Inc. | 8-K | August 20, 2025 | |
Trevi Therapeutics, Inc. | 8-K | August 7, 2025 | |
Trevi Therapeutics, Inc. | 10-Q | August 7, 2025 | |
Trevi Therapeutics, Inc. | 8-K | June 17, 2025 | |
Trevi Therapeutics, Inc. | 8-K | June 4, 2025 | |
Trevi Therapeutics, Inc. | 8-K | June 2, 2025 | |
Trevi Therapeutics, Inc. | 8-K | June 2, 2025 | |
Trevi Therapeutics, Inc. | 10-Q | May 8, 2025 | |
Trevi Therapeutics, Inc. | 8-K | May 8, 2025 | |
Trevi Therapeutics, Inc. | DEF 14A | April 29, 2025 | |
Trevi Therapeutics, Inc. | ARS | April 29, 2025 | |
Trevi Therapeutics, Inc. | DEFA14A | April 29, 2025 | |
Trevi Therapeutics, Inc. | 8-K | March 18, 2025 | |
Trevi Therapeutics, Inc. | 10-K | March 18, 2025 | |
Trevi Therapeutics, Inc. | 8-K | March 10, 2025 | |
Trevi Therapeutics, Inc. | 8-K | January 8, 2025 | |
Trevi Therapeutics, Inc. | 8-K | December 16, 2024 | |
Trevi Therapeutics, Inc. | 8-K | December 12, 2024 | |
Trevi Therapeutics, Inc. | 8-K | December 3, 2024 | |
Trevi Therapeutics, Inc. | 8-K | November 6, 2024 | |
Trevi Therapeutics, Inc. | 10-Q | November 6, 2024 | |
Trevi Therapeutics, Inc. | 8-K | October 21, 2024 | |
Trevi Therapeutics, Inc. | 8-K | October 4, 2024 | |
Trevi Therapeutics, Inc. | 8-K | October 1, 2024 | |
Trevi Therapeutics, Inc. | 8-K | August 8, 2024 | |
Trevi Therapeutics, Inc. | 10-Q | August 8, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.